GSK has announced plans to expand a facility in Scotland in a timely move to boost the production of antibiotics.
Demand for antibiotics in developing countries is on the rise and the growth if its facility will allow GSK to increase antibiotic production while also boosting the Scottish economy.
The Scottish government has given a grant to facilitate the expansion at the pharma firm’s site at Irvine, North Ayrshire. The antibiotics produced at the site are currently exported to 140 countries.
Sir Andrew Witty, chief executive of GSK, said: “The impact of this new facility will be felt here and abroad, with more antibiotics being produced for people in countries where this sort of medicine is desperately needed.”